Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses.

Introduction: Spondylarthritis (SpA) development in HLA-B27/human β2-microglobulin transgenic rat (B27-rat) is correlated with altered conventional dendritic cell (cDC) function that promotes an inflammatory pattern of CD4+T cells, including a biased expansion of pro-inflammatory Th population and imbalance of regulatory T cells cytokine profile. Transcriptomic analysis revealed that cDCs from B27-rats under express IL-27, an anti-inflammatory cytokine which induces the differentiation of IL-10 regulatory T cells and inhibits Th cells.

Methods: Here, we first investigated whether addition of exogenous IL-27 could reverse the inflammatory pattern observed in CD4 T cells.

Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis.

Objectives: Remission (REM) or low disease activity (LDA) is the treatment target in psoriatic arthritis (PsA). The objective of this study was to assess the reporting and prevalence of REM/LDA in published studies of PsA.

Methods: This was a systematic literature review of all clinical papers published in PubMed, EMBASE or Cochrane database in English between 2012 and 2019 in the field of PsA.

Increased rate of lumbar spondylolisthesis in rheumatoid arthritis: A case-control study.

Objective: The aim of this study was to compare the prevalence of lumbar spondylolisthesis (SPL) in patients suffering from low back pain (LBP) with or without rheumatoid arthritis (RA) and to identify potential factors associated with SPL in patients with RA.

Methods: We performed a case-control study. Cases and control patients had chronic LBP (more than 4 weeks).